Eledon Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates as Company Continues Clinical Pipeline Development IMCR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Pipeline Progress ABSI Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in AI Drug Discovery ALEC Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Response DOX Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower Hycroft Mining Holding Corporation HYMC Q3 2025 Earnings Narrower Loss Signals Progress in Cost Discipline